Most people with atopic dermatitis (a type of eczema) are able to control their symptoms by using topical treatments that are applied to the skin. But for some people with severe atopic dermatitis, ...
Hosted on MSN
Biologics for eczema and how they work
Biologics are used for people with severe eczema when other treatments don't work. Dupixent was the first biologic approved for eczema in 2017. Different biologics target different interleukins, which ...
Ebglyss and Dupixent are used to treat moderate to severe atopic dermatitis in certain children. Dupixent is used in children ages 6 months and older. Ebglyss is used in children ages 12 years and ...
Paris and Tarrytown, N.Y. March 21, 2023. The European Commission (EC) has approved Dupixent® (dupilumab) in the European Union (EU) to treat severe atopic dermatitis in children aged 6 months to 5 ...
Dupixent (dupilumab) is a prescription drug that works to treat certain inflammatory conditions. It does so by reducing inflammation signals in your immune system. Your response to this drug may vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results